Computational chemistry news 2022
Computational chemistry news from Cresset, including: custom force fields, molecular dynamics, molecular scaffolds, clustering algorithms in Spark, Cresset Discovery, small molecule design.
Francis Crick Institute's Translation team work with Cresset Discovery to bring computational chemistry expertise to the Crick
Cresset Discovery, provider of CADD expertise for drug discovery, collaborates with the Translation team at The Francis Crick Institute as expert computational chemist in residence.
Postdoctoral Program offers scientists unique opportunity to start their computational chemistry career
Cresset, innovative provider of software and contract research solutions for small molecule drug discovery and design, launches recruitment campaign for Postdoctoral Scientists.
Hunt for new IP for the next generation of novel agrochemicals
Globachem renews contract with Cresset Discovery.
Torx Software completes release of Torx™, a single web-based platform that will streamline small molecule discovery chemistry
Torx Software Limited, provider of technology for managing small molecule discovery chemistry, announces the release of Torx Test™ and Torx Analyze™ to complete the Torx platform. Torx is a single web-based solution that enables drug discovery teams to work together, share knowledge, manage resources and track progress throughout the Design-Make-Test-Analyze (DMTA) workflow.
OncoArendi licenses Cresset molecule design software to advance the development of new therapeutics
Cresset, innovative provider of outstanding software for molecule discovery and design, is pleased to announce that OncoArendi Therapeutics SA (WSE: OAT), a biotechnology company which specializes in the discovery and development of new drugs, has licensed Flare™ for use in its internal development programmes.
Flare V5 released: Innovative science and synergy between ligand and structure-based methods
Cresset is delighted to announce that Flare™ V5 is now available. This release of Cresset’s comprehensive platform for drug design features new and enhanced science, integration of ligand- and protein-based approaches and new and improved GUI features to increase usability.
Integration of Mcule’s purchasable compound library in Blaze™ virtual screening platform provides greater chemical diversity for outsourced projects
Cresset Discovery Services, a contract research organisation (CRO) for early phase small molecule discovery, and Mcule, provider of an online compound database, announces that Cresset Discovery Services now has access to Mcule’s purchasable compound library thorough the Blaze™ virtual screening platform.
Cresset expands its Board with the appointment of David Newble as Non-Executive Director
Cresset, innovative provider of computational solutions and services for small molecule drug discovery and design, is pleased to announce the appointment of David Newble as Non-Executive Director.
Cresset releases KNIME nodes and Pipeline Pilot components V2.6
Version V2.6 of Cresset workflow components for the KNIME™ and Pipeline Pilot™ environments are now available for all desktop solutions.
New docking feature and improved search methods released in V10.6 of Spark scaffold hopping and bioisostere replacement software
Cresset, innovative provider of outstanding software for molecule discovery and design, announces the release of Spark™ V10.6. This release of the scaffold hopping and bioisostere replacement solution further supports the exploration of new chemical space through new and improved search methods to generate innovative ideas for drug discovery projects.
4am Software Pty Ltd appointed as distributor of Cresset computational solutions for drug discovery
Brisbane, Australia and Cambridge, UK – 4am Software Pty Ltd announces its appointment as distributor of Cresset computational solutions for small molecule discovery in Australia and New Zealand.
Cresset announces Scientific Advisory Board
Cresset, innovative provider of computational solutions and services for small molecule drug discovery and design is pleased to announce the formation of a Scientific Advisory Board who will provide guidance to the Cresset science team in their research.
ZEAB Therapeutic engages Cresset Discovery Services to progress treatment for colorectal cancer
Cresset Discovery Services, a CRO for early phase discovery, has used computational tools to work with ZEAB Therapeutic, a company developing treatments for colorectal cancer, to design models for treatment of this serious disease.
Cresset and Inocardia to develop 'in silico' cardiac safety assay for drug candidate screening
Cresset Discovery Services, provider of contract research services for early phase discovery, and Inocardia, provider of cardiac safety testing models, are pleased to announce a one year collaboration to develop improved computational methods for cardiac safety assessment. This collaboration also includes the University of Coventry and UCB and is supported by EIT Digital.
Cresset joins 3D-NEONET consortium to help accelerate the development of novel therapeutics in cancer and ophthalmology
Cresset, innovative provider of computational software and services for small molecule drug discovery and design is joining the 3D-NEONET consortium of academics and SMEs.
Cresset and Liverpool ChiroChem collaborate to curate cost effective, novel and highly diverse compound libraries
Cresset, provider of software and contract research services for small molecule drug discovery, and Liverpool ChiroChem, (LCC) a chemical technology innovator that produces chiral small molecules for biotech and pharmaceutical R&D, announce a collaboration to design novel compound libraries with the maximum pharmacological diversity within the smallest library size.
Computational chemistry news from Cresset April 2019
Science, product and discovery services news from the Cresset team. Plus two major upcoming events so check out this latest newsletter for details on how to register free.
Computational chemistry news from Cresset March 2019
Cresset's science and product management team discuss patent structure-activity relationships, regression models, discovery of novel LPxC inhibitors and turning biology into novel therapeutics.
Computational chemistry news from Cresset February 2019
Latest news from Cresset, plus software tips and tricks.
Computational chemistry news from Cresset January 2019
New software releases, discovery services news and registration open for User Group Meeting.
Computational chemistry news from Cresset December 2018
Cresset's CEO reflects on major developments for software and Cresset Discovery Services.
Computational chemistry news from Cresset November 2018
New licensing options for structure-based design.
Computational chemistry news from Cresset October 2018
Chemistry news for computational, medicinal and synthetic chemists.
CRUK Manchester Institute enhances toolkit for computational and medicinal chemists
Cancer Research UK Manchester Institute (CRUK MI), has licensed Cresset's Flare for fresh insights into structure-based drug design.